Treating Blood Cancers

Celeste Bello, MD, Moffitt Cancer Center, Tampa, FL Recorded on November 21, 2024 Celeste Bello, MD Senior Member, Department of Malignant Hematology Moffitt Cancer Center Tampa, FL Join us as we dive into bispecific antibodies with Dr. Celeste Bello from Moffitt Cancer Center, exploring their mechanisms of action, current indications in lymphoma, and strategies for patient selection and administration. Dr. Bello also discusses side effects, management strategies, and emerging trends in bispecific therapies. Tune in today to learn more!

Lynn Gooden, BSN, RN, ONN-CG, Community Health Network MD Anderson Cancer Center, Indianapolis, IN and Cassie Osborne, MSN, RN, OCN, ONN-CG, Community Health Network MD Anderson Cancer Center, Indianapolis, IN Recorded on November 14, 2024 Lynn Gooden, BSN, RN, ONN-CG Oncology Navigation and Survivorship Manager Oncology Navigation Community Health Network MD Anderson Cancer Center Indianapolis, IN Cassie Osborne, MSN, RN, OCN, ONN-CG Oncology Nurse Navigator Oncology Navigation-Hematology/Sarcoma/Brain/Skin Community Health Network MD Anderson Cancer Center Indianapolis, IN Join us for this important episode, as Lynn Gooden and Cassie Osborne, nurses from the Community Health Network MD Anderson Cancer Center in Indianapolis, discuss mental health challenges faced by survivors of cancer, including the impact of long-term and late effects. They explore how a multidisciplinary team can address both physical and psychosocial needs, and caregiver involvement in decision-making and support. Resources are also highlighted for healthcare professional education, along with support resources for survivors and caregivers to enhance survivorship. Tune in to today for this insightful discussion! This episode is supported by Genentech, A Member of the Roche Group.

Kerry A. Rogers, MD, The Ohio State University, Columbus, OH Recorded on October 29, 2024 Kerry A. Rogers, MD Associate Professor Division of Hematology The Ohio State University Columbus, OH Tune in for this comprehensive overview of Chronic Lymphocytic Leukemia (CLL) with Dr. Kerry Rogers from The Ohio State University. She covers key risk factors, signs and symptoms, and the critical decision-making process between monitoring and initiating treatment. Also explored are treatment goals with consideration to how strategies may vary for different subsets of patients, and discussion on new therapies. Additionally, Dr. Rogers addresses side effect management and resources available to support both patients and their families. Listen to this informative episode today!

Jennifer R. Rushton, MD, Clinical Pathology Associates and the Baptist Health System, San Antonio, TX and Eric Severson, MD, PhD, Labcorp Oncology, Shelton, CT Recorded on July 2, 2024 Join us, as we dive into the crucial topic of biomarker testing with Dr. Jennifer Rushton from Clinical Pathology Associates and the Baptist Health System, and Dr. Eric Severson from Labcorp Oncology. They explore the role of the healthcare team in integrating biomarker testing into clinical practice and decision-making, as well as strategies for effective patient communication about its importance and implications. They also share their perspectives on the future of biomarker testing. Tune in today to learn more! Jennifer R. Rushton, MD Clinical Pathology Associates Medical Director, Pathology and Laboratory Medicine Baptist Health System San Antonio, TX Eric Severson, MD, PhD Executive Director Medical Affairs and Evidence Generation Labcorp Oncology Shelton, CT This episode is supported by Labcorp Oncology.

Stacie B. Dusetzina, PhD, Vanderbilt University Medical Center, Nashville, TN and Bethany Lilly, JD, The Leukemia & Lymphoma Society, Rye Brook, NY Recorded on September 20, 2024 Tune in to this informative episode as Dr. Stacie Dusetzina from Vanderbilt University and Bethany Lilly from The Leukemia & Lymphoma Society’s Office of Public Policy simplify the complexities of Medicare, and how healthcare professionals can help their patients navigate these decisions for better care outcomes. They discuss how plan choices affect access to cancer treatment and the financial burden of high-cost medications. They also examine the recent changes brought by the Inflation Reduction Act and what they mean for Medicare beneficiaries. Listen today to learn more about helping your patients make informed decisions, including helpful resources, in this important aspect of healthcare! Stacie B. Dusetzina, PhD Professor, Health Policy Ingram Professor of Cancer Research Vanderbilt University Medical Center Nashville, TN Bethany Lilly, JD Executive Director, Public Policy The Leukemia & Lymphoma Society Rye Brook, NY Resources mentioned in this episode:

Alex F. Herrera, MD, City of Hope Medical Center, Duarte, CA Recorded on June 27, 2024 Alex F. Herrera, MD Associate Professor Chief, Division of Lymphoma, Department of Hematology and Hematopoietic Cell Transplantation Associate Medical Director, Briskin Center for Clinical Research & City of Hope Duarte Clinical Trials Office City of Hope Medical Center Duarte, CA In this episode, Dr. Alex Herrera from City of Hope explores the intricacies of Hodgkin lymphoma, from diagnosis and monitoring techniques to treatment goals and options. He discusses emerging therapies, including the significance of clinical trials, strategies for managing side effects, long-term effects of treatment, and resources for healthcare professionals, patients, and families. Tune in to learn more today!

Shira Dinner, MD, Northwestern University, Chicago, IL and Tom Martin, MD, University of California San Francisco, San Francisco, CA Recorded on September 9, 2024 Join us for this special episode, recorded at the Twelfth Annual Meeting of the Society of Hematologic Oncology in Houston, TX! Guest host and conference attendee, Lauren Berger, Senior Director of Professional Education and Engagement at The Leukemia & Lymphoma Society, speaks with Dr. Shira Dinner, from Northwestern University, and Dr. Tom Martin, from University of California San Francisco, about their insights and key takeaways from the conference. Learn more by tuning in here! Shira Dinner, MD Associate Professor Robert H. Lurie Comprehensive Cancer Center Northwestern University Chicago, IL Tom Martin, MD Clinical Professor of Medicine, Division of Hematology/Oncology Director, Clinical Research, Hematologic Malignancies Program Co-Leader, Cancer Immunology and Immunotherapy Associate Director, Myeloma Program University of California San Francisco San Francisco, CA

Krish Patel, MD, Swedish Cancer Institute, Seattle, WA Recorded on June 6, 2024 Krish Patel, MD Director, Lymphoma Program Director, Hematologic Malignancies and Cellular Therapy Swedish Cancer Institute Seattle, WA Join us as Dr. Krish Patel from Swedish Cancer Institute explores mantle cell lymphoma, including the goals and latest advancements in treatment. He also provides insights on treating relapsed/refractory cases, discusses effective strategies for managing side effects, and highlights the importance of communication between patients and healthcare professionals for optimal care. Tune in to stay up to date on mantle cell lymphoma today!

Ximena Jordan-Bruno, MD, University of Pennsylvania, Philadelphia, PA Recorded on June 4, 2024 Ximena Jordan-Bruno, MD Assistant Professor, Division of Hematology/Oncology University of Pennsylvania Philadelphia, PA Join us for this fascinating episode, where Dr. Ximena Jordan-Bruno from the University of Pennsylvania explores hereditary myeloid and hematologic disorders, covering their classifications, mutations, and related germline predisposition syndromes. Learn about key clinical features, diagnostic approaches, the role of genetic counseling, and future research directions. Tune in today for valuable updates to enhance your understanding and practice!

Susan Hong, MD, Virginia Commonwealth University, Richmond, VA Recorded on May 21, 2024 Susan Hong, MD Director, Cancer Survivorship Program, Massey Comprehensive Cancer Center Associate Professor, School of Medicine Internal Medicine Virginia Commonwealth University Richmond, VA Tune in as Dr. Susan Hong, Cancer Survivorship Program Director at Virginia Commonwealth University’s Massey Cancer Center, discusses survivorship care in adults. She explores the intersection of healthcare professional and patient goals in survivorship care, as well as disparities and challenges impacting access and follow-up. Dr. Hong offers strategies to improve adherence to survivorship care and communication between survivors and primary care practitioners. She also shares educational resources for healthcare professionals, patients, and caregivers to support effective survivorship care. Listen to this informative episode today! This episode is supported by Genentech, Inc. & Biogen and Merck & Co., Inc.